Akèy › Kolit Ulseratif › Missouri › St. Louis
Etid klinik pou Kolit Ulseratif nan St. Louis, MO
13 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote St. Louis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Ap rekriteFaz 2
- Specialists In Gastroenterology /ID# 283939, St Louis
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ap rekriteFaz 4
- SSM Health Medical Group, Bridgeton · 15 mi lwen
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 2
- Site US-006, St Louis
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Ap rekriteFaz 2/3
- Washington University, St Louis
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ap rekriteFaz 3
- Washington University School of Medicine, St Louis
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- ak 1 plis
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Ap rekriteFaz 2
- Center for Gastrointestinal Health - Fairview Heights, Belleville · 14 mi lwen
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Ap rekriteFaz 2
- KAD Clinical Research, St Louis
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Ap rekriteFaz 3
- Washington University School of Medicine, St Louis
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 2
- KAD Clinical Research, St Louis
- Specialists in Gastroenterology, St Louis
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ap rekriteFaz 4
- Washington University School of Medicine, St Louis
BOOM-IBD2 Pivotal Clinical Trial
Ap rekrite
- Gateway GI Research (Objective Health), St Louis
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Ap rekriteFaz 2
- Mirador Therapeutics Selected Site, Bridgeton · 15 mi lwen
Etid Kolit Ulseratif nan lòt vil
- New York City, NY23 etid
- Orlando, FL22 etid
- Miami, FL21 etid
- Houston, TX17 etid
- San Antonio, TX16 etid
- Tacoma, WA15 etid
- Chicago, IL15 etid
- San Diego, CA15 etid
- Tyler, TX14 etid
- Colorado Springs, CO14 etid
- Los Angeles, CA13 etid
- Washington, DC12 etid
Lòt etid nan St. Louis
- Kansè Poumon ki pa ti selil73 etid
- Kansè nan tete64 etid
- Kansè Metastatik54 etid
- Kansè kolorektal50 etid
- Kansè pwostat46 etid
- Kansè (tout kalite)46 etid
- Kansè poumon39 etid
- Kansè ovè38 etid
- Kansè pankreyas33 etid
- Kansè Endomèt29 etid
- Karsinòm selil skuamèz tèt ak kou28 etid
- Ensifizyans kadyak26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.